We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
201
Sherwin-Williams
SHW
$78.3B
$1.39M 0.09%
6,205
+3,581
+136% +$819K
BPMC
202
DELISTED
Blueprint Medicines
BPMC
$1.38M 0.09%
30,600
+22,502
+278% +$1.01M
VIR icon
203
Vir Biotechnology
VIR
$1.47B
$1.38M 0.09%
59,099
+45,932
+349% +$1.17M
KRTX
204
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.37M 0.08%
+7,536
New +$1.44M
WEC icon
205
WEC Energy
WEC
$37.7B
$1.37M 0.08%
14,413
-466
-3% -$43.1K
CTRA
206
DELISTED
Coterra Energy
CTRA
$1.36M 0.08%
55,594
+7,012
+14% +$172K
TVTX icon
207
Travere Therapeutics
TVTX
$5.33B
$1.36M 0.08%
+60,529
New +$1.29M
MS icon
208
Morgan Stanley
MS
$337B
$1.36M 0.08%
15,503
-681
-4% -$63.6K
TGTX icon
209
TG Therapeutics
TGTX
$8.58B
$1.36M 0.08%
+90,404
New +$1.37M
ALNY icon
210
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.36M 0.08%
6,770
-6,954
-51% -$1.46M
RLAY icon
211
Relay Therapeutics
RLAY
$4.02B
$1.36M 0.08%
+82,311
New +$1.48M
EXAS
212
DELISTED
Exact Sciences
EXAS
$1.35M 0.08%
19,946
+127
+0.6% +$8.16K
NVO
213
Novo Nordisk
NVO
$216B
$1.35M 0.08%
16,944
+1,294
+8% +$91.8K
ARDX icon
214
Ardelyx
ARDX
$1.24B
$1.35M 0.08%
+281,411
New +$949K
NTLA icon
215
Intellia Therapeutics
NTLA
$1.5B
$1.35M 0.08%
36,138
+24,603
+213% +$965K
UNP icon
216
Union Pacific
UNP
$183B
$1.35M 0.08%
6,690
+317
+5% +$64.2K
SPGI icon
217
S&P Global
SPGI
$126B
$1.35M 0.08%
3,904
-182
-4% -$64.1K
NOW icon
218
ServiceNow
NOW
$102B
$1.34M 0.08%
14,440
+2,970
+26% +$259K
VZ icon
219
Verizon
VZ
$194B
$1.34M 0.08%
34,504
-28,893
-46% -$1.14M
ARWR icon
220
Arrowhead Research
ARWR
$12.1B
$1.34M 0.08%
52,802
+34,803
+193% +$1.09M
BMRN icon
221
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.33M 0.08%
13,664
-7,066
-34% -$733K
ETSY icon
222
Etsy
ETSY
$7.65B
$1.33M 0.08%
11,918
+1,644
+16% +$204K
RVMD icon
223
Revolution Medicines
RVMD
$40.2B
$1.33M 0.08%
+61,250
New +$1.51M
NVAX icon
224
Novavax
NVAX
$1.23B
$1.31M 0.08%
+189,641
New +$1.74M
SAGE
225
DELISTED
Sage Therapeutics
SAGE
$1.31M 0.08%
+31,144
New +$1.34M
7 8
9
10 11

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.